Results 11 to 20 of about 23,910 (287)

Patterns and Safety-Related Aspects of Antidepressant and Anxiolytic Use Among Healthcare Students and University Staff at a Brazilian Public University: A Cross-Sectional Study [PDF]

Pharmacy
Background/Objectives: The use of antidepressants and anxiolytics has increased worldwide, raising concerns about treatment patterns, medication safety, and rational use.
Núbia Vieira Alves, Geórgia Almeida Sant’Ana, Jorge Fernando Carrozza, Gabriela Moraes Oliveira, Carlos Ferreira Santos, Adriana Maria Calvo   +5 more
doaj   +2 more sources

The pharmacology of anxiolytics

South African Family Practice: Official Journal of the South African Academy of Family Practice/Primary Care, 2013
Given that anxiety disorders are common and chronic and often co-morbid with both medical and psychiatric conditions, effective and safe anxiolytic drugs are in great demand.
K. Outhoff
exaly   +3 more sources

The pharmacology of anxiolytics

South African Family Practice: Official Journal of the South African Academy of Family Practice/Primary Care, 2010
Given that anxiety disorders are common and chronic and often co-morbid with both medical and psychiatric conditions, effective and safe anxiolytic drugs are in great demand.
Kim Outhoff
exaly   +3 more sources

Antidepressant prescribing in transgender and nonbinary individuals diagnosed with gender dysphoria and mood or anxiety disorders [PDF]

Mental Health Clinician, 2023
Introduction: Transgender and nonbinary (TGNB) individuals are highly stigmatized members of society and are significantly at higher risk of having mood or anxiety-related disorders compared to non-TGNB individuals.
Casey M. Tiefenthaler, PharmD, BCPP, Kelly C. Lee, PharmD, MAS, APh, FCCP, BCPP   +1 more
doaj   +1 more source

Efficacy and safety of the Chinese herbal medicine Xiao Yao San for treating anxiety: a systematic review with meta-analysis and trial sequential analysis

Frontiers in Pharmacology, 2023
Introduction: The effectiveness and safety of the Chinese herbal medicine (CHM) Xiao Yao San (XYS) used for treating anxiety disorders are still unknown.
Yifan Wang, Xiaofeng Chen, Wei Wei, Yiyun Ding, Rongjuan Guo, Jia Xing, Jialin Wang   +6 more
doaj   +1 more source

Development and acceptability of a decision aid for anxiety disorder considering discontinuation of benzodiazepine anxiolytic

Frontiers in Psychiatry, 2023
AimWe aimed to develop a decision aid (DA) for individuals with anxiety disorders who consider tapering benzodiazepine (BZD) anxiolytics, and if tapering, tapering BZD anxiolytics with or without cognitive behavioral therapy (CBT) for anxiety.
Yumi Aoki, Yumi Aoki, Yoshikazu Takaesu, Yoshikazu Takaesu, Ken Inada, Hiroki Yamada, Tomohiko Murao, Toshiaki Kikuchi, Masahiro Takeshima, Masayuki Tani, Kazuo Mishima, Tempei Otsubo   +11 more
doaj   +1 more source

Stress and arterial hypertension - from pathophysiology to pharmacology [PDF]

Srpski Arhiv za Celokupno Lekarstvo, 2021
Currently, arterial hypertension is the most massive chronic non-infectious disease of mankind. It may remain undiagnosed for years, provoking later complications, such as acute heart failure, cerebrovascular stroke, myocardial infarction, renal failure,
Nenezić Nemanja, Matunović Radomir, Gudelj Ognjen, Đurić Ivica, Jančić Jasna, Samardžić Janko   +5 more
doaj   +1 more source

Prescription patterns and trends of anxiolytics and hypnotics/sedatives among child and adolescent patients with psychiatric illnesses in a psychiatric center of northern Taiwan

Taiwanese Journal of Psychiatry, 2021
Background: The prevalence of prescriptions of anxiolytics and hypnotics/sedatives for child and adolescent patients with psychiatric illnesses is increasing over the world. No studies exist to focus on the prescription trends and patterns of anxiolytics
Shu- Wen Cheng, Hsiao- Ju Sun, Hung- Yu Chan   +2 more
doaj   +1 more source

Utilization of psychotropic medicines in Romania during 1998–2018

Frontiers in Pharmacology, 2023
Background: Mental disorders can have a significant impact on patients’ life, including economic, social and individual consequences, and psychotropic medication is essential to treat these conditions.
Irina Iaru, Camelia Bucsa, Andreea Farcas, Cristina Pop, Anamaria Cristina, Sebastian Armean, Irina Brumboiu, Oliviu Vostinaru, Cristina Mogosan   +8 more
doaj   +1 more source

Analysis of regional differences in the amount of hypnotic and anxiolytic prescriptions in Japan using nationwide claims data

BMC Psychiatry, 2022
Background In Japan, there has been no investigation of regional differences in the number or amount of prescriptions of anxiolytics or hypnotics. Attributes related to the high amount of prescriptions for these drugs are unknown.
Tasuku Okui, Jinsang Park
doaj   +1 more source